NASDAQ:TELA TELA Bio (TELA) Stock Price, News & Analysis $1.26 -0.01 (-0.79%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$1.24 -0.02 (-1.98%) As of 09/25/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About TELA Bio Stock (NASDAQ:TELA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TELA Bio alerts:Sign Up Key Stats Today's Range$1.23▼$1.3150-Day Range$0.64▼$1.4152-Week Range$0.50▼$1.60Volume150,607 shsAverage Volume279,821 shsMarket Capitalization$56.88 millionP/E RatioN/ADividend YieldN/APrice Target$2.14Consensus RatingModerate Buy Company Overview TELA Bio, Inc. is a medical technology company focused on developing and commercializing implantable products for soft-tissue reconstruction. Its products are designed to support the repair and reinforcement of damaged or weakened soft tissue, including tissue affected by hernias, abdominal wall defects and other reconstructive procedures. The company’s principal product platform is OviTex Reinforced Tissue Matrix, a family of biologic implants that combines extracellular matrix tissue with a polymer reinforcement structure. TELA Bio markets OviTex products for applications including hernia repair, abdominal wall reconstruction, plastic and reconstructive surgery, and other soft-tissue procedures. The portfolio includes products tailored for different surgical techniques, anatomical sites and clinical needs. Founded in 2012 and headquartered in Malvern, Pennsylvania, TELA Bio began commercializing its products in the United States before expanding its focus to additional soft-tissue reconstruction applications and international markets. The company sells primarily through a specialized medical-device commercial organization and works with surgeons and healthcare providers involved in reconstructive surgery.AI Generated. May Contain Errors. Read More TELA Bio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks80th Percentile Overall ScoreTELA MarketRank™: TELA Bio scored higher than 80% of companies evaluated by MarketBeat, and ranked 108th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingTELA Bio has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialTELA Bio has a consensus price target of $2.14, representing about 70.1% upside from its current price of $1.26.Amount of Analyst CoverageTELA Bio has only been the subject of 2 research reports in the past 90 days.Read more about TELA Bio's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for TELA Bio are expected to grow in the coming year, from ($0.76) to ($0.44) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of TELA Bio is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of TELA Bio is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTELA Bio has a P/B Ratio of 7.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about TELA Bio's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.23% of the float of TELA Bio has been sold short.Short Interest Ratio / Days to CoverTELA Bio has a short interest ratio ("days to cover") of 2.22, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in TELA Bio has recently increased by 43.20%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTELA Bio does not currently pay a dividend.Dividend GrowthTELA Bio does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.68 News SentimentTELA Bio has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for TELA Bio this week, compared to 2 articles on an average week.Search Interest1 people have searched for TELA on MarketBeat in the last 30 days. MarketBeat Follows2 people have added TELA Bio to their MarketBeat watchlist in the last 30 days. Company Ownership4.3 / 5Insider TradingAcquiring Shares Cluster Insider Buying2 insiders have purchased shares of TELA Bio in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $119,500.00 in company stock, which represents 0.2101% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, TELA Bio insiders have bought more of their company's stock than they have sold. Specifically, they have bought $119,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders1.10% of the stock of TELA Bio is held by insiders.Percentage Held by Institutions94.35% of the stock of TELA Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about TELA Bio's insider trading history. Receive TELA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TELA Bio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TELA Stock News HeadlinesTELA Bio (NASDAQ:TELA) Stock Picked Up by Analysts at Craig HallumSeptember 27 at 1:36 AM | americanbankingnews.comCraig-Hallum initiates coverage of TELA Bio at buySeptember 26 at 1:10 AM | msn.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 27 at 1:00 AM | Stansberry Research (Ad)Craig Hallum Initiates Coverage on TELA Bio With Buy Rating, $2 Price TargetSeptember 25 at 10:01 AM | marketscreener.comMJoseph Capper Purchases 25,000 Shares of TELA Bio (NASDAQ:TELA) StockSeptember 20, 2026 | americanbankingnews.comTELA Bio (NASDAQ:TELA) Director Joseph Capper Purchases 25,000 SharesSeptember 19, 2026 | insidertrades.comTELA Bio Faces Nasdaq Delisting, Plans Reverse SplitSeptember 18, 2026 | tipranks.comTELA Bio (NASDAQ:TELA) Director Buys 25,000 Shares of StockSeptember 17, 2026 | insidertrades.comSee More Headlines TELA Stock Analysis - Frequently Asked Questions How have TELA shares performed this year? TELA Bio's stock was trading at $1.18 at the start of the year. Since then, TELA stock has increased by 6.8% and is now trading at $1.26. How were TELA Bio's earnings last quarter? TELA Bio, Inc. (NASDAQ:TELA) posted its quarterly earnings results on Monday, August, 10th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by $0.03. The company earned $19.29 million during the quarter, compared to analysts' expectations of $20.01 million. TELA Bio had a negative net margin of 51.53% and a negative trailing twelve-month return on equity of 1,320.81%. Read the conference call transcript. When did TELA Bio IPO? TELA Bio (TELA) raised $60 million in an IPO on Friday, November 8th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers. Who are TELA Bio's major shareholders? Top institutional shareholders of TELA Bio include Nantahala Capital Management LLC (13.13%), Stonepine Capital Management LLC (5.93%), BlackRock Inc. (0.84%) and UP Strategic Wealth Investment Advisors LLC (0.22%). Insiders that own company stock include Ew Healthcare Partners Fund 2,, Orbimed Advisors Llc, Antony Koblish, Joseph H Capper, Roberto Cuca, Paul Talmo and Gregory A Firestone. View institutional ownership trends. How do I buy shares of TELA Bio? Shares of TELA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TELA Bio own? Based on aggregate information from My MarketBeat watchlists, some other companies that TELA Bio investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Chevron (CVX). Company Calendar Last Earnings8/10/2026Today9/27/2026Next Earnings (Estimated)11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 3 weeks, TELA's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TELA CIK1561921 Webwww.telabio.com Phone484-320-2930FaxN/AEmployees218Year Founded2012Price Target and Rating Average Price Target for TELA Bio$2.14 High Price Target$3.00 Low Price Target$1.00 Potential Upside/Downside+70.1%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.77) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$38.83 million Net Margins-51.53% Pretax Margin-51.20% Return on Equity-1,320.81% Return on Assets-59.39% Debt Debt-to-Equity Ratio8.82 Current Ratio2.99 Quick Ratio2.38 Sales & Book Value Annual Sales$79.91 million Price / Sales0.71 Cash FlowN/A Price / Cash FlowN/A Book Value$0.16 per share Price / Book7.88Miscellaneous Outstanding Shares45,143,000Free Float44,646,000Market Cap$56.88 million OptionableOptionable Beta1.36 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:TELA) was last updated on 9/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
